Share on Facebook
Share on Twitter
Share on LinkedIn
Share by Email
Print
Ipratropium Bromide Inhalation Solution Generic Name & Formulations
Legal Class
Rx
General Description
Ipratropium bromide 0.02% (500mcg in 2.5mL); for oral inhalation; preservative-free.
Pharmacological Class
Anticholinergic.
See Also
How Supplied
Inhaler—12.9g (200 inh); inhalation soln—contact supplier
Manufacturer
Generic Availability
HFA (NO); soln (YES)
Ipratropium Bromide Inhalation Solution Indications
Indications
Bronchospasm associated with chronic bronchitis and emphysema.
Ipratropium Bromide Inhalation Solution Dosage and Administration
Adult
500mcg orally by nebulization 3–4 times daily; separate doses by 6–8 hours.
Children
Not established.
Ipratropium Bromide Inhalation Solution Contraindications
Contraindications
Allergy to atropine or its derivatives.
Ipratropium Bromide Inhalation Solution Boxed Warnings
Not Applicable
Ipratropium Bromide Inhalation Solution Warnings/Precautions
Warnings/Precautions
Not for primary treatment of acute attack. Avoid eyes. Narrow-angle glaucoma. GU obstruction. Pregnancy. Nursing mothers.
Ipratropium Bromide Inhalation Solution Pharmacokinetics
See Literature
Ipratropium Bromide Inhalation Solution Interactions
Interactions
Caution with other anticholinergics.
Ipratropium Bromide Inhalation Solution Adverse Reactions
Adverse Reactions
Bronchitis, COPD exacerbation, dyspnea, headache, anticholinergic effects; paradoxical bronchospasm, hypersensitivity reactions.
Ipratropium Bromide Inhalation Solution Clinical Trials
See Literature
Ipratropium Bromide Inhalation Solution Note
Not Applicable
Ipratropium Bromide Inhalation Solution Patient Counseling
See Literature
